Endocrine Tumors of Pancreas Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Endocrine Tumors of Pancreas. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Endocrine Tumors of Pancreas Indian Medical PG Question 1: A 38-year-old female presents to the physician with complaints of excessive thirst and urination for the past 4 weeks. Her appetite has been normal and she has not had diarrhea. Blood chemistry showed mildly elevated glucose and glucagon. Physical examination reveals tenderness in the left upper quadrant and an erythematous necrotizing skin eruption on her legs. Radiographic studies show a tumor in the pancreas. Which of the following cells is responsible for this lesion?
- A. Beta cell
- B. Acinar cell
- C. Delta cell
- D. Alpha cell (Correct Answer)
Endocrine Tumors of Pancreas Explanation: ### Alpha cell
- The constellation of **excessive thirst and urination (polyuria/polydipsia)**, **mildly elevated glucose**, **elevated glucagon**, **necrolytic migratory erythema (NME)**, and a **pancreatic tumor** is highly characteristic of a **glucagonoma**. [1]
- Glucagonomas originate from **pancreatic alpha cells**, which are responsible for glucagon production. [2]
### Beta cell
- **Beta cell tumors** (insulinomas) primarily cause **hypoglycemia** due to excessive insulin secretion, which is antithetical to the patient's symptoms of elevated glucose. [2]
- While beta cell tumors can be found in the pancreas, they are not associated with necrolytic migratory erythema or glucagon excess. [1]
### Acinar cell
- **Acinar cell carcinomas** are exocrine pancreatic tumors that can cause symptoms related to their size and local invasion (e.g., pain, weight loss, jaundice) but are not typically associated with specific hormonal syndromes such as glucagon excess.
- They do not cause the characteristic skin rash or metabolic disturbances seen in this patient.
### Delta cell
- **Delta cells** produce **somatostatin**, and tumors originating from these cells (somatostatinomas) can cause symptoms like diabetes, steatorrhea, and gallstones.
- However, they do not typically present with elevated glucagon or the characteristic necrolytic migratory erythema.
Endocrine Tumors of Pancreas Indian Medical PG Question 2: A 35-year-old woman presents with 6-month history of skin rash and fatigue. Physical examination shows pallor and a necrotizing erythematous skin rash of her lower body. Laboratory studies reveal mild anemia and fasting blood glucose of 160 mg/dL. A CT scan of the abdomen demonstrates a 2-cm mass in the pancreas. Which of the following is the most likely diagnosis?
- A. Insulinoma
- B. Glucagonoma (Correct Answer)
- C. Gastrinoma
- D. Carcinoid tumor
Endocrine Tumors of Pancreas Explanation: ***Glucagonoma***
- The necrotizing erythematous skin rash (necrolytic migratory erythema), mild anemia, hyperglycemia (fasting blood glucose 160 mg/dL), and a pancreatic mass are classic features of a **glucagonoma**. [1]
- **Glucagon** excess leads to skin rash, glucose intolerance due to its counter-regulatory effects on insulin, and often anemia. [1]
*Insulinoma*
- An insulinoma typically presents with symptoms of **hypoglycemia** (e.g., sweating, palpitations, confusion), especially in the fasting state. [2]
- While it involves a pancreatic mass, the patient's hyperglycemia and specific skin rash are inconsistent with insulinoma. [2]
*Gastrinoma*
- Gastrinomas cause **Zollinger-Ellison syndrome**, characterized by severe peptic ulcer disease, abdominal pain, and diarrhea due to excessive **gastrin** production. [1]
- The patient's symptoms, particularly the skin rash and hyperglycemia, are not typical of a gastrinoma.
*Carcinoid tumor*
- Carcinoid tumors can arise in various locations, including the pancreas, but typically produce **serotonin** and other vasoactive substances. [1]
- Symptoms usually include **flushing**, diarrhea, and bronchospasm (carcinoid syndrome), which are absent in this patient's presentation. [1]
Endocrine Tumors of Pancreas Indian Medical PG Question 3: A 45-year-old gentleman has undergone truncal vagotomy and pyloroplasty for bleeding duodenal ulcer seven years ago. Now he has intractable recurrent symptoms of peptic ulcer. All of the following suggest the diagnosis of Zollinger-Ellison syndrome, except:
- A. Ulcers in proximal jejunum and lower end of esophagus
- B. Basal acid output of 15 meq/hour
- C. Serum gastrin value of 500 pg/ml
- D. Serum gastrin value of 200 pg/ml with secretin stimulation (Correct Answer)
Endocrine Tumors of Pancreas Explanation: ***Serum gastrin value of 200 pg/ml with secretin stimulation***
- A **positive secretin stimulation test** for Zollinger-Ellison syndrome (ZES) is indicated by a rise in serum gastrin of **≥ 200 pg/mL (or 110 pg/mL depending on the reference range)** above baseline after secretin administration.
- A value of 200 pg/ml with secretin stimulation is not diagnostic if the baseline is not known or if the rise from baseline is not significant (i.e., less than 200 pg/ml absolute rise or less than 110 pg/ml rise depending on the specific criteria used). In the context of the other options, this relatively lower value is the *least* indicative of ZES.
*Basal acid output of 15 meq/hour*
- In a patient with prior vagotomy, a **basal acid output (BAO) of 15 meq/hour** is significantly elevated and highly suggestive of Zollinger-Ellison syndrome, as vagotomy aims to reduce acid secretion.
- Normal BAO is typically < 5 mEq/hr, and a BAO > 15 mEq/hr (or > 6 mEq/hr in patients who have undergone prior acid-reducing surgery) is strongly indicative of excessive gastric acid production characteristic of ZES [1].
*Serum gastrin value of 500 pg/ml*
- A **fasting serum gastrin level of 500 pg/ml** is markedly elevated (> 150-200 pg/mL is often considered suspicious), especially in the presence of recurrent ulcers, and is a strong indicator for Zollinger-Ellison syndrome [1].
- This value is well above the normal range (typically < 100 pg/ml) and falls into the range where gastrinoma should be highly suspected [1].
*Ulcers in proximal jejunum and lower end of esophagus*
- The presence of **ulcers in unusual locations** such as the **proximal jejunum** is highly characteristic of Zollinger-Ellison syndrome due to the profound acid hypersecretion.
- Esophageal ulcers, particularly at the lower end, are also common due to severe gastroesophageal reflux caused by high acid output overwhelming esophageal protective mechanisms.
Endocrine Tumors of Pancreas Indian Medical PG Question 4: What is the most specific marker for pancreatic acinar cell carcinoma?
- A. Chromogranin
- B. Synaptophysin
- C. CK7
- D. Trypsin (Correct Answer)
Endocrine Tumors of Pancreas Explanation: ***Trypsin***
- **Trypsin**, along with other pancreatic enzymes like lipase and alpha-1-antitrypsin, is a specific marker for **pancreatic acinar cell carcinoma** due to the tumor's characteristic differentiation towards acinar cells.
- The detection of these enzymes in tumor tissue or serum can aid in the diagnosis and differentiation of this rare pancreatic malignancy.
*Chromogranin*
- **Chromogranin** is a marker for **neuroendocrine tumors**, not specifically acinar cell carcinoma.
- While some pancreatic tumors can have neuroendocrine features, chromogranin is not the most specific marker for a pure acinar cell differentiation.
*Synaptophysin*
- **Synaptophysin** is another marker primarily associated with **neuroendocrine differentiation**.
- Its presence indicates a neuroendocrine tumor rather than an acinar cell carcinoma, which derives from exocrine acinar cells.
*CK7*
- **CK7** (Cytokeratin 7) is a broad-spectrum **cytokeratin** often expressed in adenocarcinomas of various origins, including pancreatic ductal adenocarcinoma.
- While pancreatic tumors can express CK7, it is not specific for acinar cell carcinoma and is more commonly associated with ductal differentiation.
Endocrine Tumors of Pancreas Indian Medical PG Question 5: What is the imaging modality of choice for localizing neuroendocrine tumors?
- A. USG
- B. CT
- C. MRI
- D. Somatostatin receptor scintigraphy (Correct Answer)
Endocrine Tumors of Pancreas Explanation: ***Somatostatin receptor scintigraphy***
- **Somatostatin receptor scintigraphy** is the imaging modality of choice given that most neuroendocrine tumors (NETs) express a high density of somatostatin receptors.
- **68Ga-DOTATATE PET/CT** is the **current preferred technique**, offering superior sensitivity (>90%) and specificity compared to older methods like Indium-111 pentetreotide (Octreoscan).
- This functional imaging allows for **whole-body evaluation** and can detect both primary tumors and metastases, including small lesions that may be missed on conventional anatomical imaging.
- Particularly valuable for detecting occult primary tumors and staging metastatic disease.
*USG*
- **Ultrasound** is useful for initial screening or evaluating superficial NETs, particularly in organs like the pancreas or liver.
- However, its utility is limited by **operator dependence**, gas artifact, and its inability to detect small or deeply located tumors effectively.
- Does not provide functional information about somatostatin receptor expression.
*CT*
- **Computed tomography** provides good anatomical detail and is useful for assessing tumor size, local invasion, and detecting liver metastases.
- While helpful for anatomical characterization, CT can **miss small lesions** (especially <1 cm) and does not provide functional information about receptor status.
- Often used in combination with functional imaging for treatment planning.
*MRI*
- **Magnetic resonance imaging** offers excellent soft tissue contrast and is particularly useful for NETs in the liver and pancreas.
- Superior to CT for detecting liver metastases due to better soft tissue resolution.
- However, MRI has **lower sensitivity for small or widespread lesions** compared to somatostatin receptor imaging and does not provide functional receptor information.
Endocrine Tumors of Pancreas Indian Medical PG Question 6: Which brain tumor has the worst prognosis in children?
- A. Brainstem glioma (Correct Answer)
- B. Craniopharyngioma
- C. Cerebellar astrocytoma
- D. Pineal body tumor
Endocrine Tumors of Pancreas Explanation: ***Brainstem glioma***
- **Diffuse intrinsic pontine gliomas (DIPG)** are particularly aggressive, typically unresponsive to conventional therapies, and have a median survival of less than one year.
- Their critical location in the **brainstem** makes surgical resection extremely difficult and often impossible without causing severe neurological deficits [2].
*Craniopharyngioma*
- While they can be challenging to treat due to their proximity to vital structures like the **optic chiasm** and **hypothalamus**, they are generally benign and have a good prognosis with complete surgical resection.
- They tend to recur if not completely removed, but recurrence is often amenable to further treatment.
*Cerebellar astrocytoma*
- These are often **low-grade (pilocytic astrocytomas)** and have an excellent prognosis, especially if surgical gross total resection is achieved [2].
- They are usually cystic and well-demarcated, making them more amenable to curative surgical removal.
*Pineal body tumor*
- The prognosis of pineal region tumors varies greatly depending on the **histology** (e.g., germinoma, pineoblastoma, pineocytoma) [1].
- While some are aggressive (like pineoblastomas), a significant portion, such as germinomas, are highly sensitive to **radiation therapy** and have a relatively good prognosis [1].
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1140-1141.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1319-1320.
Endocrine Tumors of Pancreas Indian Medical PG Question 7: What is the most common type of tumour of Vermiform Appendix?
- A. Germ cell tumour
- B. Adenocarcinoma
- C. Papillary cell tumour
- D. Carcinoid tumour (Correct Answer)
Endocrine Tumors of Pancreas Explanation: ***Carcinoid tumour***
- **Carcinoid tumors** (neuroendocrine tumors) are the **most common primary neoplasms of the appendix**, accounting for approximately 30-50% of all appendiceal tumors. [1]
- They typically originate from the **enterochromaffin cells** in the appendiceal mucosa and are often discovered incidentally during appendectomy for suspected appendicitis.
- Most appendiceal carcinoids are **small (<2 cm), benign, and located at the tip** of the appendix. [1]
*Adenocarcinoma*
- **Adenocarcinomas** are the second most common primary tumor of the appendix, representing about 10-20% of cases.
- These **epithelial malignancies** include mucinous and non-mucinous subtypes and can present with symptoms mimicking acute appendicitis.
- Mucinous adenocarcinomas may lead to **pseudomyxoma peritonei** if they rupture.
*Germ cell tumour*
- **Germ cell tumors** are exceptionally rare in the appendix and more commonly arise from the gonads (testes, ovaries) or midline structures.
- These tumors originate from **pluripotent germ cells** and are not a significant consideration for appendiceal neoplasms.
*Papillary cell tumour*
- This term describes a **morphological growth pattern** (papillary architecture) rather than a specific primary tumor classification.
- While some epithelial tumors may exhibit papillary features, this is **not a recognized primary tumor type** of the appendix.
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 375-376.
Endocrine Tumors of Pancreas Indian Medical PG Question 8: What is the difference between acute and chronic pancreatitis?
- A. Acute pancreatitis has reversible changes. (Correct Answer)
- B. Alcohol causes only acute pancreatitis.
- C. Chronic pancreatitis shows no signs of inflammation.
- D. Acute pancreatitis affects mainly the younger population.
Endocrine Tumors of Pancreas Explanation: ### Explanation
**1. Why Option A is Correct:**
The fundamental distinction between acute and chronic pancreatitis lies in the **reversibility of parenchymal damage**. [1]
* **Acute Pancreatitis** is characterized by an acute inflammatory response to premature activation of pancreatic enzymes (trypsinogen to trypsin). [3] If the underlying cause (e.g., gallstones) is removed and complications are managed, the pancreas can return to its normal histological and functional state.
* **Chronic Pancreatitis** involves irreversible destruction of the exocrine parenchyma, fibrosis, and, in late stages, destruction of endocrine parenchyma (Islets of Langerhans). [1]
**2. Why the Other Options are Incorrect:**
* **Option B:** Alcohol is a major cause of **both** acute and chronic pancreatitis. [3][4] In fact, chronic alcohol consumption is the most common cause of chronic pancreatitis in adults. [1]
* **Option C:** Chronic pancreatitis is defined by **prolonged inflammation** associated with irreversible morphologic changes. [1] While the cellular infiltrate differs (lymphocytes and macrophages vs. neutrophils), inflammation is a core component of the disease process.
* **Option D:** There is no strict age-based rule. While acute pancreatitis due to gallstones often affects middle-aged individuals, and chronic pancreatitis often affects middle-aged men (alcohol-related), both can occur across various age groups depending on the etiology (e.g., cystic fibrosis in children). [3]
**3. NEET-PG High-Yield Pearls:**
* **Hallmark of Chronic Pancreatitis:** Fibrosis and atrophy of acini. [1] The most specific imaging finding is **pancreatic calcification**.
* **Morphology of Acute Pancreatitis:** Look for **fat necrosis** (chalky white deposits due to calcium soap formation) and **liquefactive necrosis** of the parenchyma.
* **Key Enzyme:** Trypsin is the "master switch" that activates other proenzymes (proelastase, prophospholipase). [3]
* **Sentinel Event:** Intracellular activation of enzymes within **acinar cells**. [2][3]
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 889-895.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 890-891.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 889-890.
[4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 406-407.
Endocrine Tumors of Pancreas Indian Medical PG Question 9: What is the most common primary site of malignancy that leads to secondary metastases in the pancreas?
- A. Lung (Correct Answer)
- B. Breast
- C. Colon
- D. Stomach
Endocrine Tumors of Pancreas Explanation: **Explanation:**
Secondary (metastatic) tumors of the pancreas are relatively rare compared to primary pancreatic adenocarcinoma. However, when they occur, they most commonly originate from the **Lung**.
**1. Why Lung is Correct:**
The lung is the most frequent primary site for pancreatic metastases, followed closely by the kidney (Renal Cell Carcinoma), breast, and melanoma. Lung cancer, particularly Small Cell Lung Cancer (SCLC) and Adenocarcinoma, has a high propensity for hematogenous spread [1]. In autopsy series, the pancreas is involved in approximately 5–10% of patients who die from metastatic lung cancer.
**2. Analysis of Incorrect Options:**
* **Breast (Option B):** While breast cancer is a common source of systemic metastasis, it ranks behind lung and kidney as a primary source for pancreatic secondaries.
* **Colon (Option C):** Colorectal cancer typically metastasizes to the liver via the portal venous system [4]. Pancreatic involvement is uncommon and usually occurs via direct extension rather than hematogenous spread.
* **Stomach (Option D):** Gastric cancer usually involves the pancreas through **direct contiguous spread** (especially from the posterior wall) rather than true distant metastasis.
**3. High-Yield Clinical Pearls for NEET-PG:**
* **Most common primary pancreatic malignancy:** Ductal Adenocarcinoma (Head > Body > Tail) [2].
* **Most common source of pancreatic metastasis (Autopsy):** Lung Cancer.
* **Most common source of pancreatic metastasis (Surgical/Clinical series):** Renal Cell Carcinoma (RCC). *Note: If both Lung and RCC are options, Lung is the standard textbook answer for "most common primary site."*
* **Imaging:** Metastatic lesions are often hypervascular (especially RCC) or multiple, whereas primary pancreatic cancer is typically a solitary, hypovascular mass [3].
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 724-725.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 898-899.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, p. 897.
[4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 408-409.
Endocrine Tumors of Pancreas Indian Medical PG Question 10: Intraductal papillary mucinous neoplasm is a precursor of which of the following entities?
- A. Mucinous cystic neoplasm
- B. Mucinous non-cystic neoplasm
- C. Ductal adenocarcinoma (Correct Answer)
- D. Solid pseudopapillary neoplasm
Endocrine Tumors of Pancreas Explanation: **Explanation:**
**Intraductal Papillary Mucinous Neoplasm (IPMN)** is a macroscopic, mucin-producing epithelial neoplasm arising within the main pancreatic duct or its branches. It is a well-recognized **precursor lesion** that follows a progressive dysplasia-carcinoma sequence, eventually leading to **Invasive Ductal Adenocarcinoma** [1].
**Why Ductal Adenocarcinoma is correct:**
Pancreatic ductal adenocarcinoma (PDAC) typically arises from three precursor lesions [1]:
1. **PanIN (Pancreatic Intraepithelial Neoplasia):** Microscopic (<1cm), most common.
2. **IPMN:** Macroscopic, involving the ductal system.
3. **MCN (Mucinous Cystic Neoplasm):** Macroscopic, characterized by "ovarian-type" stroma.
IPMNs are characterized by papillary growths and can be categorized into low, intermediate, or high-grade dysplasia before progressing to invasive ductal adenocarcinoma.
**Why other options are incorrect:**
* **Mucinous Cystic Neoplasm (MCN):** This is a distinct precursor lesion itself, not a consequence of IPMN. It occurs almost exclusively in females and is located in the tail/body of the pancreas.
* **Mucinous non-cystic neoplasm:** This is not a standard pathological entity in the context of pancreatic precursor progression.
* **Solid Pseudopapillary Neoplasm (SPN):** This is a low-grade malignant tumor typically seen in young women. It arises from pluripotent cells and follows a different molecular pathway (̢-catenin mutations), unrelated to the IPMN-adenocarcinoma sequence.
**High-Yield Clinical Pearls for NEET-PG:**
* **Location:** IPMNs most commonly involve the **head of the pancreas**.
* **Gender:** Unlike MCNs (female-dominant), IPMNs occur more frequently in **men**.
* **Imaging:** Classic "fish-mouth" appearance of the Ampulla of Vater due to profuse mucin secretion.
* **Molecular Genetics:** IPMNs are frequently associated with **GNAS** and **KRAS** mutations [1].
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 897-901.
More Endocrine Tumors of Pancreas Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
